Literature DB >> 263292

Lack of arginine vasopressin response to central dopamine blockade in normal adults.

K S Kendler, R E Weitzman, R T Rubin.   

Abstract

Haloperidol, a central nervous system dopamine blocker, was given im to seven normal volunteers at a dose level (1.0 mg) known to have central nervous system effects. Plasma PRL levels rose sharply in response to haloperidol, but plasma arginine vasopressin levels did not change significantly. These data do not support the hypothesis of a prominent dopamine neurotransmitter regulation of arginine vasopressin secretion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 263292     DOI: 10.1210/jcem-47-1-204

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Dopaminergic modulation of evoked vasopressin release from the isolated neurohypophysis of the rat. Possible involvement of endogenous opioids.

Authors:  K Racké; H Ritzel; B Trapp; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

2.  The effects of benztropine and pargyline on the response of cat carotid chemoreceptors to sodium cyanide, acetylcholine and dopamine [proceedings].

Authors:  R J Docherty
Journal:  J Physiol       Date:  1979-07       Impact factor: 5.182

Review 3.  Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs.

Authors:  O Spigset; K Hedenmalm
Journal:  Drug Saf       Date:  1995-03       Impact factor: 5.606

4.  Central effects of dopamine on vasopressin release in the normally hydrated and water-loaded rat.

Authors:  M L Forsling; H Williams
Journal:  J Physiol       Date:  1984-01       Impact factor: 5.182

Review 5.  Pathophysiology of Drug-Induced Hyponatremia.

Authors:  Gheun-Ho Kim
Journal:  J Clin Med       Date:  2022-09-30       Impact factor: 4.964

Review 6.  The Role of Vasopressin V2 Receptor in Drug-Induced Hyponatremia.

Authors:  Sua Kim; Chor Ho Jo; Gheun-Ho Kim
Journal:  Front Physiol       Date:  2021-12-10       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.